Emkay Global Financial' research report on Firstsource Solutions
firstsource (fsol) reported a largely in-line operating performance in q2. revenue grew 2.3% qoq to usd265mn (2.0% cc), a tad below our estimate. ebitm expanded by 20bps qoq to 11.5%, marking the 4th consecutive quarter of margin expansion, though a tad below our estimated 11.6%. fsol signed four large deals (each with acv exceeding usd5mn; two representing additional business from the top 5 accounts) and added 10 new logos in q2 (including four strategic). it added 19 strategic logos between q2fy25 and q1fy26; of these, 13 have already achieved usd5mn relationship size on a ttm basis and four from q1 still have ramping-up runway. fsol retained its fy26 revenue growth guidance of 13-15% in cc terms (excluding pdc’s acquisition, which is pending regulatory approval), implying a cqgr of 3.3-5.6% over q3- q4, and ebitm guidance of 11.25-12%. revenue growth is set to accelerate in h2, fueled by revenue from the healthcare bpaas deal, phased ramp-ups of large deals, a robust deal pipeline (>usd1bn acv), and healthy headcount additions made in q2 which would support potential demand. we largely retain our fy26-28e eps (<1% change), factoring in the in-line q2 results.
Outlook
we retain reduce, with an unchanged tp of rs350, at 24x sep-27e eps.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.